13F filer · CIK 2088557
Defilade Capital Management, L.P.
EMERYVILLE, CA · filing since Q4 2025 · last filing Aug 14, 2026
Reported value
$746.9M
+$34.8M vs prior
Positions
39
New / sold out
20 / 12
Added / reduced
8 / 10
Turnover
59.8%
buys $436.5M · sells $441.4M
Top-10 weight
46.5%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | VEEVA SYS INC | +236,709 | – | +$42.0M |
| New | BIOMARIN PHARMACEUTICAL INC | +682,005 | – | +$39.0M |
| New | BAXTER INTL INC | +1,459,380 | – | +$31.1M |
| New | INSULET CORP | +176,932 | – | +$26.9M |
| New | THERMO FISHER SCIENTIFIC INC | +51,934 | – | +$26.0M |
| New | ABBOTT LABORATORIES | +285,778 | – | +$25.9M |
| New | ASCENDIS PHARMA A/S | +94,843 | – | +$25.3M |
| New | SOLVENTUM CORP | +316,454 | – | +$24.4M |
| New | MEDTRONIC PLC | +303,301 | – | +$23.7M |
| Added | LLYELI LILLY & CO | +18,390 | +88.9% | +$22.1M |
18 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | SCHEIN HENRY INC | -624,037 | -100.0% | $-46.0M |
| Sold out | BECTON DICKINSON & CO | -279,210 | -100.0% | $-43.9M |
| Reduced | REVOLUTION MEDICINES INC | -233,145 | -73.8% | $-43.7M |
| Sold out | DEXCOM INC | -538,762 | -100.0% | $-33.8M |
| Sold out | INTUITIVE SURGICAL INC | -67,681 | -100.0% | $-31.2M |
| Sold out | NEUROCRINE BIOSCIENCES INC | -209,932 | -100.0% | $-27.7M |
| Reduced | DENALI THERAPEUTICS INC | -968,103 | -71.2% | $-24.9M |
| Reduced | ZIMMER BIOMET HOLDINGS INC | -261,735 | -45.2% | $-22.5M |
| Reduced | ICU MED INC | -148,591 | -58.4% | $-21.8M |
| Sold out | INTEGER HLDGS CORP | -213,027 | -100.0% | $-18.7M |
12 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | LLYELI LILLY & CO | 39,086 | $46.9M | 6.28% |
| 2 | PFIZER INCCOM | 1,771,743 | $42.7M | 5.71% |
| 3 | VEEVA SYS INCCL A COM | 236,709 | $42.0M | 5.62% |
| 4 | BIOMARIN PHARMACEUTICAL INCCOM | 682,005 | $39.0M | 5.22% |
| 5 | PTC THERAPEUTICS INCCOM | 433,699 | $35.4M | 4.74% |
| 6 | BAXTER INTL INCCOM | 1,459,380 | $31.1M | 4.17% |
| 7 | INSMED INCCOM PAR $.01 | 281,838 | $30.0M | 4.02% |
| 8 | ZIMMER BIOMET HOLDINGS INCCOM | 317,426 | $27.3M | 3.66% |
| 9 | INSULET CORPCOM | 176,932 | $26.9M | 3.61% |
| 10 | THERMO FISHER SCIENTIFIC INCCOM | 51,934 | $26.0M | 3.49% |
29 more rows. Subscribe for $29/month to see every row, download the data and use the API.